Cargando…
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
Besides the isolation and identification of major histocompatibility complex I-restricted peptides from the surface of cancer cells, one of the challenges is eliciting an effective antitumor CD8+ T-cell-mediated response as part of therapeutic cancer vaccine. Therefore, the establishment of a solid...
Autores principales: | Feola, Sara, Chiaro, Jacopo, Martins, Beatriz, Russo, Salvatore, Fusciello, Manlio, Ylösmäki, Erkko, Bonini, Chiara, Ruggiero, Eliana, Hamdan, Firas, Feodoroff, Michaela, Antignani, Gabriella, Viitala, Tapani, Pesonen, Sari, Grönholm, Mikaela, Branca, Rui MM, Lehtiö, Janne, Cerullo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989416/ https://www.ncbi.nlm.nih.gov/pubmed/35314027 http://dx.doi.org/10.7554/eLife.71156 |
Ejemplares similares
-
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2023) -
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine
por: Feola, Sara, et al.
Publicado: (2022) -
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2021) -
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors
por: Chiaro, Jacopo, et al.
Publicado: (2023) -
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
por: Ylösmäki, Erkko, et al.
Publicado: (2021)